Signal transmission occurs in two stages. A long preganglionic fiber releases acetylcholine onto nicotinic receptors in an autonomic ganglion. A shorter postganglionic fiber then releases acetylcholine near the target organ, where it acts mainly through muscarinic receptors. This sequential arrangement links central origins in the brainstem or sacral spinal cord with controlled organ responses.
The two receptor classes operate at different points in the pathway. Nicotinic receptors receive acetylcholine within autonomic ganglia, allowing the preganglionic signal to pass to the postganglionic neuron. Muscarinic receptors primarily mediate the later effect at the target organ. Distinguishing these sites helps explain how cholinergic drugs can modify autonomic transmission and organ activity.
The response depends on the target organ receiving the postganglionic signal. In the heart, activity can slow the heart rate; in the eyes, it can constrict the pupils. Within the digestive system, it can increase secretions and intestinal movement. These varied outcomes show how one signaling system coordinates multiple internal functions while supporting rest and energy conservation.
A focused study can examine changes in heart rate, pupil diameter, digestive secretions, and intestinal movement. Together, these observations represent cardiovascular, ocular, and gastrointestinal effects associated with parasympathetic activity. Tracking several responses is useful because the system coordinates multiple organs rather than producing a single uniform outcome.
They are relevant whenever altered autonomic coordination may affect involuntary organ function. Because their activity influences cardiac rate, pupil constriction, digestive secretion, and intestinal movement, studying these pathways can help organize observations of internal-organ dysfunction. The biology is therefore useful for connecting changes in specific physiological responses with broader autonomic regulation.
The pathway identifies two pharmacological points of interest: nicotinic receptors in autonomic ganglia and mainly muscarinic receptors on target organs. Understanding this sequence helps relate a drug's cholinergic action to its possible site of influence. Such knowledge supports interpretation of treatments designed to modify autonomic signaling and the involuntary functions it regulates.